ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,675.29
1.08%
US Tech 100
19,114.00
-0.63%
다우존스 지수
41,964.63
0.92%
Bitcoin
85,350.00
-1.78%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE

  6. Takeda Pharmaceutical Company Ltd (TAK) 시세

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd (TAK)

Taku Gold Corp
15.13
-0.05
(-0.33%)
마감 20 3월 5:00AM
15분 지연
15.13
0.00
( 0.00% )
시간외 단일가: 8:00PM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
15.13
매수가
-
매도가
-
거래량
2
0.00 일간 변동폭 0.00
12.575 52주 범위 15.24
market_cap
47.478B
전일 종가
15.13
개장가
-
최근 거래 시간
1
@
15.13
마지막 거래 시간
17:32:47
재정 규모
-
VWAP
-
평균 볼륨(3m)
1,771,956
발행 주식
3,138,026,928
배당수익률
4.09%
주가수익률
1.07
주당순이익(EPS)
45.91
매출
4.28T
순이익
144.07B

Takeda Pharmaceutical Company Ltd 정보

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Diversified
웹사이트
www.takeda.co.jp
본부
Chuo, Tokyo, Jpn
설립됨
1984
Takeda Pharmaceutical Company Ltd is listed in the Pharmaceutical Preparations sector of the 뉴욕 증권거래소 with ticker TAK. The last closing price for Takeda Pharmaceutical was US$15.13. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of US$ 12.575 to US$ 15.24.

Takeda Pharmaceutical currently has 3,138,026,928 shares in issue. The market capitalisation of Takeda Pharmaceutical is US$47.48 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 1.07.

TAK 최신 뉴스

추가 뉴스

Form 13F-HR - Quarterly report filed by institutional managers, Holdings
Edgar (US Regulatory)
12 2월 2025
TAK (-0.33%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.130.8666666666671515.2414.89149041815.09834849DR
41.359.7968069666213.7815.2413.7795159220314.76927562DR
122.0715.849923430313.0615.2412.86177195613.77828635DR
260.281.8855218855214.8515.2412.86175269313.82841986DR
520.684.7058823529414.4515.2412.575181091413.76810192DR
1560.080.53156146179415.0517.1512.28218278814.48535049DR
2600.533.630136986314.62012.28216627115.2974158DR

TAK - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical share price?
The current share price of Takeda Pharmaceutical is US$ 15.13
How many Takeda Pharmaceutical shares are in issue?
Takeda Pharmaceutical has 3,138,026,928 shares in issue
What is the market cap of Takeda Pharmaceutical?
The market capitalisation of Takeda Pharmaceutical is USD 47.48B
What is the 1 year trading range for Takeda Pharmaceutical share price?
Takeda Pharmaceutical has traded in the range of US$ 12.575 to US$ 15.24 during the past year
What is the PE ratio of Takeda Pharmaceutical?
The price to earnings ratio of Takeda Pharmaceutical is 1.07
What is the cash to sales ratio of Takeda Pharmaceutical?
The cash to sales ratio of Takeda Pharmaceutical is 0.04
What is the reporting currency for Takeda Pharmaceutical?
Takeda Pharmaceutical reports financial results in JPY
What is the latest annual turnover for Takeda Pharmaceutical?
The latest annual turnover of Takeda Pharmaceutical is JPY 4.28T
What is the latest annual profit for Takeda Pharmaceutical?
The latest annual profit of Takeda Pharmaceutical is JPY 144.07B
What is the registered address of Takeda Pharmaceutical?
The registered address for Takeda Pharmaceutical is 4-1-1 DOSHOMACHI, CHUO-KU, CHUO, TOKYO, 540-8645
What is the Takeda Pharmaceutical website address?
The website address for Takeda Pharmaceutical is www.takeda.co.jp
Which industry sector does Takeda Pharmaceutical operate in?
Takeda Pharmaceutical operates in the PHARMACEUTICAL DIVERSIFIED sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PRAProAssurance Corp
US$ 23.32
(50.06%)
5.45k
RYAMRayonier Advanced Materials Inc
US$ 6.59
(20.04%)
28
GDOTGreen Dot Corporation
US$ 8.99
(19.07%)
5
DEIDouglas Emmett Inc
US$ 18.59
(15.68%)
8
VELVelocity Financial Inc
US$ 21.99
(15.13%)
12
SHOSunstone Hotel Investors Inc
US$ 6.01
(-39.11%)
4
SMHISEACOR Marine Holdings Inc
US$ 4.51
(-17.10%)
4
LGF.BLions Gate Entertainment Corp
US$ 7.21
(-15.18%)
20
BLWBlackRock Limited Duration Income Trust
US$ 12.01
(-14.34%)
7
JBGSJBG SMITH Properties
US$ 14.01
(-10.99%)
7
QBTSD Wave Quantum Inc
US$ 10.10
(-4.72%)
977.82k
BABAAlibaba Group Holding Limited
US$ 136.94
(-4.37%)
815.37k
NIONIO Inc
US$ 4.945
(-4.35%)
797.72k
IONQIonQ Inc
US$ 23.00
(-1.29%)
341.5k
SESSES AI Corporation
US$ 0.5538
(0.71%)
318.23k

TAK Discussion

게시물 보기
Monksdream Monksdream 2 주 전
TAK under. $16
👍️0
Monksdream Monksdream 12 월 전
TAK over $10
👍️0
Boing x 2 Boing x 2 2 년 전
Just saying,

https://www.takeda.com/newsroom/newsreleases/2022/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-us-food-and-drug-administration

4 months or less until an answer. Expedited review is six months or less now. It was accepted Nov 22nd.

Big if we get FDA apprvoval. ETF's in the know are sucking up shares.

Other approved drug has serious side effects vs. ours.

300M cases a year from mosquito bites.

Boing X 2
👍️0
Phosphene Phosphene 4 년 전
Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

https://www.businesswire.com/news/home/20201208005955/en/Takeda%E2%80%99s-Pipeline-Has-Potential-to-Contribute-Significantly-to-Revenue-Growth-Over-Next-Decade
👍️0
Phosphene Phosphene 4 년 전
Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO

https://www.reuters.com/article/health-coronavirus-takeda-vaccines-idUSKBN27M0F7
👍️0
Phosphene Phosphene 4 년 전
MIT-Takeda program launches

Research projects will harness the power of artificial intelligence to positively impact human health.

https://news.mit.edu/2020/mit-takeda-program-launches-research-ai-and-human-health-0618
👍️0
rising rising 7 년 전
Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

ADR is 3:1 - NICE!
60 percent upside
Added 36.83 US stock
Added 29.38 US cash


Not a bad deal!
👍️0
rising rising 7 년 전
So how does the Shire shareholder make out on this deal?

Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

Where is the 60percent premium to Close of March 27 2018 at shire 128.87
👍️0
trendmkr trendmkr 9 년 전
Takeda article: enGene Shines with a Host of Big Name Collaborations

http://marketexclusive.com/engene-shines-with-a-host-of-big-name-collaborations/1281/
👍️0

최근 히스토리

NYSE
TAK
Takeda Pharmaceutical
FTSE
4GGL
FTSE 4Good Global
AMEX
MEXS
ASX
RIMOC
Rimfire Pacific Mining NL
ASX
IVROA
Investigator Resources
TG
A3L3QM
CocaCola Europacific Par...
AMEX
MGLD
Marygold Companies
BOV
BOBR3F
BOMBRIL ON
ASX
PUAOD
Peak Minerals
BIT
S29103
Societe Generale Effekten
ASX
ILUCD
Iluka Resources
ASX
HYDDA
Hydrix
ASX
CETDA
VanEck Investments
BITI
ITMC
Ftse Italia Mid Cap
TSXV
AUGC
AU Gold
ASX
TANN
BetaShares Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지